Hormone Replacement Therapy After Breast Cancer: A Systematic Review and Quantitative Assessment of Risk – 2001 Journal of Clinical Oncology

admin LL Breast Cancer

The Journal of Clinical Oncology is a major cancer study journal.  The authors consider that Hormone replacement therapy is typically withheld from women with breast cancer because of concern that it might increase the risk of recurrence. The purpose of this study was to quantify the risk of recurrent breast cancer associated with Hormone Replacement Therapy among breast cancer survivors.  The findings of these researchers suggest that Hormone Replacement Therapy after a diagnosis of breast cancer has no significant effect on breast cancer recurrence.